Skip to content

A Prospective Clinical Study for Laparoscopic D3 Dissection With Preservation of Left Colic Artery in Rectal Cancer

A Prospective Randomized Clinical Study for Laparoscopic D3 Lymph Node Dissection With Preservation of Left Colic Artery in Rectal Cancer Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02753465
Enrollment
200
Registered
2016-04-27
Start date
2016-04-30
Completion date
2019-12-31
Last updated
2016-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Neoplasms

Keywords

Rectal Neoplasms, anastomosis, OS, DFS, LCA, laparoscopic surgery

Brief summary

During surgery for rectal cancer, there is considerable controversy regarding the optimal level of ligation of the inferior mesenteric artery. Several studies have demonstrated the benefit of high ligation of the inferior mesenteric artery for the rectal cancer in order to achieve block dissection of lymph node metastases along the root of the inferior mesenteric artery. In contrast, other studies have shown a significant decrease in blood flow after inferior mesenteric artery clamping that may increase the risk of anastomotic ischemia and the long-term outcomes were not significantly different between high ligation of the inferior mesenteric artery and low ligation. So, a modified procedure was suggested to dissect fatty tissues and nodes in the angle between the inferior mesenteric artery and the left colic artery and the artery was ligated below the left colic artery. In the present clinical trial, the investigators perform laparoscopic surgery with this management strategy in rectal cancer. Thus, the goal of this study is to investigate the short-term and oncologic long-term outcomes associated with laparoscopic lymph node dissection around the inferior mesenteric artery with preservation of the left colic artery for rectal cancer.

Detailed description

During surgery for rectal cancer, there is considerable controversy regarding the optimal level of ligation of the inferior mesenteric artery.There has been a differentiation between a high versus low ligation of the inferior mesenteric artery related to whether or not the ligation is above (high ligation) or below (low ligation) the left colic artery. Several studies have demonstrated the benefit of high ligation of the inferior mesenteric artery for the rectal cancer in order to achieve block dissection of lymph node metastases along the root of the inferior mesenteric artery. Excision of the apical lymph node at the root of the inferior mesenteric artery is thought to be necessary for radical resection of rectal cancer because apical lymph node resection contributes to improve lymph node retrieval rates and the accuracy of tumour staging. In contrast, other studies have shown a significant decrease in blood flow after inferior mesenteric artery clamping that may increase the risk of anastomotic ischemia. Patients with high ligation of inferior mesenteric artery had a 3.8 times higher chance of leaking than those with low ligation. Several studies confirmed that the long-term outcomes were not significantly different between high ligation of the inferior mesenteric artery and low ligation. So, a modified procedure was suggested to dissect fatty tissues and nodes in the angle between the inferior mesenteric artery and left colic artery and the artery was ligated below the left colic artery, which represented a compromise between the high and low ligation. Recently, several studies have described laparoscopic lymph node dissection around the inferior mesenteric artery with preservation of the left colic artery for rectosigmoid colon cancer. However, there are a few reports that describe the clinical outcomes associated with this management strategy. Furthermore, the long-term outcomes for laparoscopic lymphadenectomy around the inferior mesenteric artery with rectal cancer have seldom been reported. In the present clinical trial, the investigators perform laparoscopic surgery with this management strategy in rectal cancer. Thus, the goal of this study is to investigate the short-term and oncologic long-term outcomes associated with laparoscopic lymph node dissection around the inferior mesenteric artery with preservation of the left colic artery for rectal cancer.

Interventions

PROCEDUREleft colic artery

Laparoscopic D3 Lymph Node Dissection with preservation of left colic artery

PROCEDUREHigh ligation

Laparoscopic D3 Lymph Node Dissection with ligation above the left colic artery

Sponsors

Fudan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. pathological confirmed rectal adenocarcinoma 2. solitary radical resectable tumors 3. tumor located at 5-15cm from the anus

Exclusion criteria

1. recurrent cases 2. emergency including obstruction, bleeding or perforation 3. severe abdominal adhesions 4. severe malnutrition can not be improved before surgery 5. can not tolerate to surgery due to severe comorbidities of heart, lung, liver or kidney 6. refractory hypoproteinemia or diabetes mellitus 7. previous or concomitant other cancers 8. the patients performed APR or hartmann surgery

Design outcomes

Primary

MeasureTime frameDescription
anastomotic leak rate30 days since the date of surgerypercentage of patients occuring anastomotic leak within 30 days since surgery
Number of lymph node dissection10 days since the date of surgery
Overall survival rate3 years since the date of surgery3 years total survival rate after surgery
disease-free survival rate3 years since the date of surgery3 years disease-free survival rate after surgery

Secondary

MeasureTime frame
30-day mortality ratewithin 30 days since the date of surgery

Countries

China

Contacts

Primary ContactXin-Xiang LI, Ph.D
lxx1149@163.com+86-18017312900
Backup ContactLEI LIANG, Ph.D
LLKNIGHT115@163.COM+86-18121299307

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026